BIOCRYST PHARMACEUTICALS INC - BCRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Deerfield Mgmt, L.P. | 6.81% | 14,341,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Deerfield Management Company, L.P. | 6.81% | 14,341,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Deerfield Partners, L.P. | 6.81% | 14,341,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | James E. Flynn | 6.81% | 14,341,000 | View |
| Feb 09, 2026 | SCHEDULE 13G | STATE STREET CORPORATION | 5.3% | 11,073,211 | View |
| Nov 12, 2025 | SCHEDULE 13G | RA Capital Management, L.P. | 7.3% | 15,302,186 | View |
| Nov 12, 2025 | SCHEDULE 13G | Peter Kolchinsky | 7.3% | 15,302,186 | View |
| Nov 12, 2025 | SCHEDULE 13G | Rajeev Shah | 7.3% | 15,302,186 | View |
| Nov 12, 2025 | SCHEDULE 13G | RA Capital Healthcare Fund, L.P. | 7.3% | 15,302,186 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.